| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/06/2005 | CN1634118A Antivirus formulation containing polysaccharide polyanion zinc salt and its preparing process |
| 07/06/2005 | CN1634116A Stavudine sustained release tablet and its preparing process |
| 07/06/2005 | CN1634114A Clindamycin phosphate orally disintegrating tablet |
| 07/06/2005 | CN1634113A Method for preparing azithromycin superfine powder by ultrasound homogenization dissolvent diffusion method |
| 07/06/2005 | CN1634112A Azithromycin gel formulation and its preparing process |
| 07/06/2005 | CN1634108A Tinea resisting cream |
| 07/06/2005 | CN1634103A Clarithromycin orally disintegrating tablet |
| 07/06/2005 | CN1634092A Gel formulation of gentamycin sulfate and its preparing process |
| 07/06/2005 | CN1634074A 头孢匹胺组合物 Cefpiramide composition |
| 07/06/2005 | CN1634073A Orally disintegrating tablet of levofloxacin and its pharmaceutical salt |
| 07/06/2005 | CN1634072A Levofloxacin dripping pills and its preparing process |
| 07/06/2005 | CN1634067A Gancilorvir dispersable tablet and its preparation |
| 07/06/2005 | CN1634064A Itraconazole structurization emulsion composition and its preparing method |
| 07/06/2005 | CN1634061A Pharmaceutical formulation of pseudoephenrine hydrochloride and its preparing process |
| 07/06/2005 | CN1634060A Gelatin formulation of dextromethorphan hydrobromide and its preparing method |
| 07/06/2005 | CN1634059A Pseudoephedrine hydrochloride, dextromethorphan hydrobromide and chlorphenamine maleates gel formulation and its preparing process |
| 07/06/2005 | CN1634048A Berberine hydrochloride granule for masking flavor and its preparation |
| 07/06/2005 | CN1634047A Gynaecologic inflammation therapeutic drug |
| 07/06/2005 | CN1634044A Pharmaceutical composition containing amoxicillin trihydrate and clavulanate potassium |
| 07/06/2005 | CN1634031A AIDS therapeutic drug and its uses |
| 07/06/2005 | CN1634001A Alkannin nano-granule and its preparation method |
| 07/06/2005 | CN1634000A Cinnamic aldehyde series preparation and its preparation process |
| 07/06/2005 | CN1633996A Tuberculosis therapeutic injection |
| 07/06/2005 | CN1209462C Metabolist product of cyathus against mycobacterium tuberculosis and preparation thereof |
| 07/06/2005 | CN1209364C Amine salt of cefathiamiding, its preparing method and application |
| 07/06/2005 | CN1209358C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/06/2005 | CN1209172C Method for providing cosmetic/medical therapy |
| 07/06/2005 | CN1209163C Meningococcal vaccine and its preparing method |
| 07/06/2005 | CN1209158C Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
| 07/06/2005 | CN1209154C Novel preparation process of Qingkailing injection |
| 07/06/2005 | CN1209145C External use medicine for treating blister sore |
| 07/06/2005 | CN1209143C Pharmaceutical composition for treating hepatitis |
| 07/06/2005 | CN1209131C Powder for lowering aminopherase of hepatitis B patients and its preparing process |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914122 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6914058 1-(p-(thiomorpholino)phenyl)-1,2,3-triazole derivatives |
| 07/05/2005 | US6914054 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic |
| 07/05/2005 | US6914052 Dideoxynucleoside analog compounds containing a dideoxy ribofuranosyl moiety that exhibit selective anti-viral activity coupled with substantially low toxicity toward host cells; treatment of HIV |
| 07/05/2005 | US6913907 Enterococcus faecalis polynucleotides encoding EF059 |
| 07/05/2005 | US6913755 Amino acid substituted DNA sequences for use as vaccines against streptococcus |
| 07/05/2005 | US6913753 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/05/2005 | US6913750 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 07/05/2005 | US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
| 07/05/2005 | US6913746 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 07/05/2005 | CA2298639C Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2183972C Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 07/05/2005 | CA2179530C Cyclic polyamines |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2123811C Type i and type ii surface antigens associated with staphylococcus epidermidis |
| 07/05/2005 | CA2089748C Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders |
| 06/30/2005 | WO2005059138A1 Methods and compounds for altering the load of hepatitis virus |
| 06/30/2005 | WO2005058888A2 Oxazolidinone-quinolone hybrid antibiotics |
| 06/30/2005 | WO2005058343A1 Bactericide against streptococcus mutans and streptococcus sobrinus |
| 06/30/2005 | WO2005058231A2 Rifamycin analogs and uses thereof |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2005017093A3 Polypeptides of streptococcus pyogenes |
| 06/30/2005 | WO2005005466A3 Nucleic and protein sequences from the hxhv virus and uses thereof |
| 06/30/2005 | WO2005004926A8 Dendritic cell infiltrativity activating composition and immune activator |
| 06/30/2005 | WO2004110392A3 Compositions and methods for treating coronavirus infection and sars |
| 06/30/2005 | WO2004046159A8 Antiviral nucleoside derivatives |
| 06/30/2005 | WO2004035611A3 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003106479A3 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143461 inhibiting transmission of sexually transmitted diseases by applying a mixture of suramin sodium and a surfactant; including other active microbiocides, fungicides, viricides, bactericides, antifertility agents |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143423 Antiulcer; antisecretory; solubility, bioavailability; slow hydrolysis; full inhibition of acid secretion in oral therapy by prolonged presence in body; 1-(carboxythiophenesulfonyl)- 2-(substituted pyridylmethylsulfinyl) benzimidazoles; also with LANSOPRAZOLE, OMEPRAZOLE, PANTOPRAZOLE, or RABEPRAZOLE |
| 06/30/2005 | US20050143413 imidazo[4,5-c]quinoline-4-amine compounds; can induce the biosynthesis of various cytokines; use treating viral diseases and neoplastic diseases |
| 06/30/2005 | US20050143406 Use of e.g. 2-butylamino-2-demethoxy-hypocrellin B in sonodyamic therapy to treat cancer, skin disorders, infections, autoimmune diseases |
| 06/30/2005 | US20050143393 Bactericides; infection therapy; topical administering |
| 06/30/2005 | US20050143392 3,1'-didehydro-3[2"(3'",3'"-dimethyl-prop-2-enyl)-3"-indolyl methylene]-6-methylpiperazine-2,5-dione; Fermentation of a mangrove-associated fungus Penicillium chrysogenum; solvent extraction; antibiotic against Gram-negative Vibrio cholerae; alternative to Tetracycline |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143387 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints |
| 06/30/2005 | US20050143376 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones |
| 06/30/2005 | US20050143368 Chemical compounds |
| 06/30/2005 | US20050143346 Blocks the phosphorylation of ceramide and sphingosine, thereby maintaining high concentration of ceramide and sphingosine; has inhibitory activity of sphingosine kinase |
| 06/30/2005 | US20050143341 Novel substance having physiological property, method for producing the same and uses thereof |
| 06/30/2005 | US20050143337 Nucleic acid-based compounds and methods of use thereof |
| 06/30/2005 | US20050143307 Biological activity that prevents the binding of formyl methionine-leucine-phenylalanine (fMLP) and/or C5a protein to granulocytes; acute and chronic inflammation reactions and HIV infection |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050143284 Vaccination |
| 06/30/2005 | US20050143283 with a chelating agent; improves the solution stability; lyophilized; antithrombotic agent |
| 06/30/2005 | US20050142615 Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection |
| 06/30/2005 | US20050142546 Assays for identifying modulators of rhomboid polypeptides |
| 06/30/2005 | US20050142535 Ogligonucleotides comprising alternating segments and uses thereof |
| 06/30/2005 | US20050142222 Boehmeria frutescens Thunberg, Boehmeria nivea or the nettle family extracts; without using of toxic organic solvents |
| 06/30/2005 | US20050142191 Pharmaceutical formulations of amyloid inhibiting compounds |
| 06/30/2005 | US20050142188 Pellets having a core coated with an antifungal and a polymer |
| 06/30/2005 | US20050142149 Virulence genes and proteins, and their use |
| 06/30/2005 | US20050142145 Derivatives of choline binding proteins for vaccines |
| 06/30/2005 | US20050142144 Epitope sequences |
| 06/30/2005 | US20050142115 Papilloma pseudovirus and preparation |
| 06/30/2005 | US20050142114 Preferentially targeting liposome to mammalian immune cell such as myeloid progenitor cell, monocyte, dendritic cell, macrophage or T-lymphocyte by administering to cell a liposome comprising an active agent and an outer surface that comprises a targeting ligand that binds marker on surface of cell |
| 06/30/2005 | US20050142110 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 06/30/2005 | US20050142069 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 06/30/2005 | US20050139485 applying a resonance conditioning frequencies, spectral energy pattern to a battery cell reaction system, act to accelerate and catalysis the reaction |